HOME >> MEDICINE >> NEWS
Hormone may offer hope for treating some behavioral disorders

SAN FRANCISCO Do you ever wonder how the brain determines its response to emotional stimuli? Researchers have now shown a correlation between secretin, a hormone found in gut and brain tissue, and how the brain responds to affective stimuli. Details and implications of this study will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 May 1, 2004.

Studies using magnetic resonance imaging (MRI) methods have found that individuals with a range of behavioral disorders including schizophrenia, depression, bipolar illness and autism have abnormal amygdala activation in response to facial emotions and other social stimuli. The amygdala, a part of the limbic brain, has emerged as one of the most critical areas influencing how we respond emotionally. It has also been shown to play an important role in emotional learning and in the attribution of emotional significance to stimuli. These MRI findings point to amygdala dysfunction as a potential neurobiological factor in the development of these disorders.

Recent evidence suggests that secretin may modulate the functional response of the amygdala. "We wanted to test the hypothesis that administration of secretin alters amygdala responsiveness to affective stimuli in healthy adult males," notes study author Deborah Yurgelun-Todd, PhD, of McLean Hospital and Harvard Medical School, Belmont, Mass.

The ability to detect and measure the effects of secretin in the brain is important in three ways. It is consistent with animal studies that report altered amygdala response after secretin administration. It also indicates that administration of this agent can be monitored using neuroimaging methods, therefore providing an important method for studying both brain and behavioral effects of secretin. Finally, and perhaps most promising given that abnormalities of amygdala function have been implicated in a variety of behavioral and psychiatric disorders, studi
'"/>

Contact: Kathy Stone
kstone@aan.com
651-695-2763
American Academy of Neurology
27-Apr-2004


Page: 1 2

Related medicine news :

1. Hormone therapy increases risk of urinary incontinence
2. Hormone therapy controversy raises drug safety issues
3. Endocrine Society and Hormone Foundation call for increased research
4. Hormone therapy may still offer important health benefits to postmenopausal women
5. Hormone found to protect bones
6. Hormone released by bone marrow cells may hasten recovery from brain injury
7. Hormones increase side effects, complicate treatment decision for prostate cancer patients
8. Hormones and drugs that control blood pressure also control malaria infection
9. Hormone replacement therapy reviewing the evidence
10. Hormone prompts adult stem cells to differentiate into islet cells
11. Hormone therapy study stopped due to increased breast cancer risk, lack of overall benefit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hormone may offer hope for treating some behavioral disorders

(Date:8/3/2015)... ... August 03, 2015 , ... Novation, ... Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can help ... , Annually, more than 8.6 million adverse drug events are reported in ...
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... Los Angeles, CA (PRWEB) , ... August 03, 2015 , ... ... emergency dental services to help patients in need. Most people know that general health ... hospital emergency. Unfortunately, a fewer amount of people know where to turn to during ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, ... contract lifecycle management solution, as well as announced the date of its next ... and ease of contract management tasks as well as enhancements to the customer ...
(Date:8/3/2015)... ... August 03, 2015 , ... Results ... Navigant Center for Healthcare Research and Policy Analysis show widespread support for the ... said they agreed or strongly agreed that the controversial law passed in 2010 ...
Breaking Medicine News(10 mins):Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3
(Date:8/3/2015)... August 3, 2015 /OFF ... Group LLC, PIV757417 The following release: "Biotech Advancements ... Drug Products & Treatments for Critical-Care Patients With ... time: 3 Aug 2015 12:30 GMT ... military surgical research and top-tier universities for identifying ...
(Date:8/3/2015)... Fla. , Aug. 3, 2015  Charleston ... initiation of its second clinical development program with ... candidate, CL-H1T.  CL-H1T contains fast-dissolving ... being developed as a treatment for migraine headache ... "Many patients with migraine headaches also ...
(Date:8/3/2015)... ZIONA, Israel , August 3, ... TASE: BVXV) today announced it received the statistical analysis of ... vaccine (M-001), administered in the BVX-005 phase II trial which ... future strains which did not exist at the time of ... (flu) strain that caused the epidemic in the ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
Cached News: